{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:06:05Z","timestamp":1792994765504,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["102789\/Z\/13\/A"],"award-info":[{"award-number":["102789\/Z\/13\/A"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12014\/1"],"award-info":[{"award-number":["MC_UU_12014\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jhep.2021.04.045","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T11:10:01Z","timestamp":1620472201000},"page":"462-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens"],"prefix":"10.1016","volume":"75","author":[{"given":"Rajiv","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrece","family":"Ahovegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Niebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jhep.2021.04.045_bib1","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1016\/S2214-109X(15)00156-4","article-title":"Disparity in market prices for hepatitis C virus direct-acting drugs","volume":"3","author":"Andrieux-Meyer","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.jhep.2021.04.045_bib2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.045_bib3","series-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis c virus infection","year":"2018"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2019.07.025","article-title":"Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: implications for global elimination of hepatitis C","volume":"71","author":"Childs","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jhep.2017.06.035","article-title":"Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries","volume":"67","author":"da Silva Filipe","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hep.30225","article-title":"Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r","volume":"69","author":"Fourati","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2468-1253(18)30382-0","article-title":"Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial","volume":"4","author":"Gupta","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2021.04.045_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.jhep.2021.04.045_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12859-018-2459-9","article-title":"GLUE: a flexible software system for virus sequence data","volume":"19","author":"Singer","year":"2018","journal-title":"BMC bioinformatics"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0956462416630910","article-title":"Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis","volume":"28","author":"Jordan","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"Pt 8","key":"10.1016\/j.jhep.2021.04.045_bib13","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1099\/vir.0.048835-0","article-title":"Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1","volume":"94","author":"Li","year":"2013","journal-title":"J\u00a0Gen Virol"},{"issue":"Part 9","key":"10.1016\/j.jhep.2021.04.045_bib14","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1099\/vir.0.011569-0","article-title":"Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa","volume":"90","author":"Markov","year":"2009","journal-title":"J\u00a0Gen Virol"},{"issue":"Pt 6","key":"10.1016\/j.jhep.2021.04.045_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1099\/vir.0.038315-0","article-title":"Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns","volume":"93","author":"Li","year":"2012","journal-title":"J\u00a0Gen Virol"},{"issue":"Pt 3","key":"10.1016\/j.jhep.2021.04.045_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1099\/vir.0.049668-0","article-title":"Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant","volume":"94","author":"Lu","year":"2013","journal-title":"J\u00a0Gen Virol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S2468-1253(18)30343-1","article-title":"Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial","volume":"4","author":"Wei","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-9071(199602)48:2<191::AID-JMV12>3.0.CO;2-I","article-title":"Genotype determination of hepatitis C virus from northern India: identification of a new subtype","volume":"48","author":"Panigrahi","year":"1996","journal-title":"J\u00a0Med Virol"},{"issue":"Pt 8","key":"10.1016\/j.jhep.2021.04.045_bib19","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/vir.0.065128-0","article-title":"Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e","volume":"95","author":"Li","year":"2014","journal-title":"J\u00a0Gen Virol"},{"issue":"100","key":"10.1016\/j.jhep.2021.04.045_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2014.07.006","article-title":"Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa","volume":"464\u2013465","author":"Iles","year":"2014","journal-title":"Virology"},{"issue":"9207","key":"10.1016\/j.jhep.2021.04.045_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of\u00a0hepatitis\u00a0C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jhep.2021.04.045_bib22","doi-asserted-by":"crossref","first-page":"44947","DOI":"10.1038\/srep44947","article-title":"The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia","volume":"7","author":"Al-Qahtani","year":"2017","journal-title":"Scientific Rep"},{"issue":"5","key":"10.1016\/j.jhep.2021.04.045_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jmv.21788","article-title":"Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia","volume":"83","author":"Abreha","year":"2011","journal-title":"J\u00a0Med Virol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/380821","article-title":"Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis","volume":"189","author":"van Asten","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.jhep.2021.04.045_bib25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00705-008-0227-2","article-title":"Hepatitis C virus genotypes in two different patient cohorts in Johannesburg, South Africa","volume":"153","author":"Prabdial-Sing","year":"2008","journal-title":"Arch Virol"},{"key":"10.1016\/j.jhep.2021.04.045_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.meegid.2016.01.016","article-title":"First genome characterization of a novel hepatitis C virus genotype 5 variant","volume":"39","author":"Henquell","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.jhep.2021.04.045_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"12","key":"10.1016\/j.jhep.2021.04.045_bib28","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/j.1469-0691.2011.03665.x","article-title":"High genetic diversity including potential new subtypes of hepatitis C virus genotype 6 in Lao People's Democratic Republic","volume":"17","author":"H\u00fcbschen","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2021.04.045_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.virol.2014.12.025","article-title":"An expanded taxonomy of hepatitis C virus genotype 6: characterization of 22 new full-length viral genomes","volume":"476","author":"Li","year":"2015","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157438","article-title":"Natural polymorphisms conferring resistance to HCV protease and polymerase inhibitors in treatment-na\u00efve HIV\/HCV Co-infected patients in China","volume":"11","author":"Zhou","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jhep.2021.04.045_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jviromet.2017.08.017","article-title":"Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay","volume":"249","author":"Manee","year":"2017","journal-title":"J\u00a0Virol Methods"},{"issue":"4","key":"10.1016\/j.jhep.2021.04.045_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.30342","article-title":"Highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments","volume":"69","author":"Davis","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"11","key":"10.1016\/j.jhep.2021.04.045_bib33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.jhep.2021.04.045_bib34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2020.05.029","article-title":"Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub-Saharan Africa and South East Asia","volume":"73","author":"Nguyen","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2021.04.045_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jvh.12795","article-title":"Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4","volume":"25","author":"Camus","year":"2018","journal-title":"J\u00a0viral Hepat"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib36","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2015.07.063","article-title":"Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection","volume":"149","author":"Gane","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2021.04.045_bib37","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2017.12.015","article-title":"Efficacy of NS5A inhibitors against hepatitis C virus\u00a0genotypes 1-7 and escape variants","volume":"154","author":"Gottwein","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhep.2021.04.045_bib38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.29837","article-title":"Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors","volume":"69","author":"Smith","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.jhep.2021.04.045_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02205-18","article-title":"Impact of preexisting hepatitis C virus genotype 6 NS3, NS5A, and NS5B polymorphisms on the <em>In\u00a0vitro<\/em> potency of direct-acting antiviral agents","volume":"63","author":"McPhee","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2021.04.045_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13322","article-title":"Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection","author":"Dietz","year":"2020","journal-title":"J\u00a0viral Hepat"},{"issue":"Pt 8","key":"10.1016\/j.jhep.2021.04.045_bib41","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1099\/vir.0.010330-0","article-title":"Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t","volume":"90","author":"Li","year":"2009","journal-title":"J\u00a0Gen Virol"},{"issue":"8","key":"10.1016\/j.jhep.2021.04.045_bib42","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.02.017","article-title":"HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models","volume":"154","author":"Pham","year":"2018","journal-title":"Gastroenterology"},{"issue":"1, Part 3","key":"10.1016\/j.jhep.2021.04.045_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jfma.2019.07.021","article-title":"High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays","volume":"119","author":"Chen","year":"2020","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jhep.2021.04.045_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28636","article-title":"Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir","volume":"64","author":"Schreiber","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.jhep.2021.04.045_bib45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2017.11.032","article-title":"Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir\/velpatasvir in the phase III studies","volume":"68","author":"Hezode","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jhep.2020.01.025","article-title":"Real-world effectiveness and safety of glecaprevir\/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis","volume":"72","author":"Lampertico","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2021.04.045_bib47","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jhep.2021.04.045_bib48","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1473-3099(19)30118-5","article-title":"Medical countermeasures during the 2018 ebola virus disease outbreak in the North Kivu and Ituri provinces of the democratic republic of the Congo: a rapid genomic assessment","volume":"19","author":"Mbala-Kingebeni","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jhep.2021.04.045_bib49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2468-1253(17)30257-1","article-title":"Hepatitis C and the absence of genomic data in low-income countries: a barrier on\u00a0the road to elimination?","volume":"2","author":"Niebel","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2021.04.045_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.045_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.meegid.2013.08.014","article-title":"A\u00a0panel of 16 full-length HCV genomes was characterized in China belonging to genotypes 1-6 including subtype 2f and two novel genotype 6 variants","volume":"20","author":"Xu","year":"2013","journal-title":"Infect Genet Evol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782100310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782100310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:55:56Z","timestamp":1777510556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782100310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S016882782100310X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.045","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}